Microdosing has recently been getting a lot of popularity but all for the right reasons. Microdosing involves taking tiny amounts of recreational drugs to help improve an individual’s mood and mental acuity.
The University of California, Davis whilst conducting a research on rats discovered that microdosing Psilocybin can actually help provide relief from anxiety and help with curing depression. Psilocybin mushrooms, commonly known as magic mushrooms or shrooms, are a polyphyletic, informal group of fungi that contain psilocybin and psilocin. Psilocybin is a naturally psychedelic compound developed by the combination of several different species of mushrooms.
For it’s benefits in helping to cure depression and overcome anxiety, it has propelled advocates to sue the courts to uplift the ban on drug prohibition. Bruce Tobin, a psychotherapist and a research professor at Victoria University has been amongst those that have been on the forefront promoting the uplift of the ban and highlighting it’s benefits for cancer patients and patients that are facing other fatal diseases. Patients prior to the diagnosis of a fatal disease such as cancer tend to fall into “end of life” depression and Psilocybin has showed results in curing that depression.
Psilocybin isn’t a new compound to health workers in Canada rather they have been working for quite some time to find a way to legalize microdosing of Psilocybin for treatment of those that are terminally ill. Tobin stated that it toke more than 3 years for health Canada to respond to the numerous applications sent in by those wanting to legalize Psilocybin and uplift the ban on drug prohibition for medicinal purposes.
Tobin in an interview with Avis Favaro a medical correspondent to CTV news, said that he noticed a slight behavioral change among patients already taking psychotherapy, feeling more relaxed and less stressed after using the substance.
Tobin’s campaign is sponsored by his own group, named "TheraPsil: Therapeutic Psilocybin for Canadians” where they believe that the substance should be legalized for patients that are terminally ill.
Researcher’s believe that legal medicinal mushrooms have a number of benefits from treating depression to helping control alcohol addiction. Research programs have also found that supervised and regular use of Psilocybin can benefit many psychiatric disorders,self growth, spiritual growth, can boost confidence aswell as enhance the creativity of one’s mind.
Two centers in Canada are conducting researches over the benefits and side effects of using medicinal psilocybin. The Mississauga University of Toronto recently opened a Psychedelics Studies Center making it the world’s first medical research on microdosing Psilocybin.
The Griffith University has stated that the mechanisms of Psilocybin along with the other compounds is unlike any other they have seen in their usual choice of medicinal care. “ I think we’re entering a new era of mental health care” said Griffiths.
Only a year after the legalization of recreational weed in Canada, health workers are currently working to legalize the use of Psilocybin in the treatment of patients that are mentally ill aswell.